Breaking News on Global Pharmaceutical Technology & Manufacturing

Caliper gets OK for Zymark purchase

04-Jul-2003

Related topics: APIs (active pharmaceutical ingredients), Regulatory & Safety

Caliper Technologies has been given the go-ahead by the US federal Trade Commission for its $71 million cash and stock acquisition of Zymark, a specialist in laboratory automation and robotics equipment. The companies expect the transaction to conclude by the end of this month.

When announcing the deal in June, Caliper chief executive James Knighton said that bringing Zymark on board would immediately add to earnings put the company on track to reach profitability in 2005.

 

The company is expecting the combination of its lab-on-a-chip technologies with Zymark's businesses to give it a lift into new areas such as new areas, such as analytical biochemistry, diagnostics, genetic analysis and genomics/proteomics.

 

Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions

© 2012 - William Reed Business Media SAS - All rights reserved.